Human embryonic stem cell-derived cardiomyocytes can mobilize 1,4,5-inositol trisphosphate-operated [ca2+]i stores: The functionality of angiotensin-II/endothelin-1 signaling pathways

Annals of the New York Academy of Sciences

Volumn 1188, Issue , 2010, Pages 68-77

  Sedan, Oshra ^a   Dolnikov, Katya ^a   Zeevi Levin, Naama ^a,b   Fleishmann, Noa ^a   Spiegel, Idit ^a   Berdichevski, Sasha ^a   Amit, Michal ^a,b   Itskovitz Eldor, Joseph ^a,b   Binah, Ofer ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

1,4,5 inositol trisphosphate; Angiotensin II; Calcium transients; Contractions; Endothelin 1; Human embryonic stem cell derived cardiomyocytes

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1,4,5 INOSITOL TRIPHOSPHATE; 2 AMINOETHOXYPHENYL BORATE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; BORIC ACID; CALCIUM; ENDOTHELIN 1; INOSITOL TRISPHOSPHATE; INOSITOL TRISPHOSPHATE 1 RECEPTOR; INOSITOL TRISPHOSPHATE 2 RECEPTOR; PHOSPHATE; PHOSPHOLIPASE C; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL THERAPY; CONFERENCE PAPER; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HUMAN; IMMUNOFLUORESCENCE; MUSCLE FIBER CONTRACTION; NONHUMAN;

EID: 77649108158     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05085.x     Document Type: Conference Paper

References (45)

1. Wong, B. W., M. Rahmani, N. Rezai, et al. 2005. Progress in heart transplantation. Cardiovasc. Pathol. 14: 176-180.
2. Hunt, S. A. & F. Haddad. 2008. The changing face of heart transplantation. J. Am. Coll. Cardiol. 52: 587-598.
3. Habib, M., O. Caspi & L. Gepstein. 2008. Human embryonic stem cells for cardiomyogenesis. J. Mol. Cell. Cardiol. 45: 462-1174
4. Segers, V. F. & R. T. Lee. 2008. Stem-cell therapy for cardiac disease. Nature 451: 937-942.
5. Passier, R., L. W. van Laake & C. L. Mummery. 2008. Stem-cell-based therapy and lessons from the heart. Nature 453: 322-329.
6. Etzion, S., A. Battler, I. M. Barbash, et al. 2001. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J. Mol. Cell. Cardiol. 33: 1321-1330. (Pubitemid 32613424) (Pubitemid 32613424)
7. Ménard, C., A. A. Hagège, O. Agbulut, et al. 2005. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 366: 1005-1012. (Pubitemid 41323036) (Pubitemid 41323036)
8. Laflamme, M. A., J. Gold, C. Xu, et al. 2005. Formation of human myocardium in the rat heart from human embryonic stem cells. Am. J. Pathol. 167: 663-671.
9. Haider, H. Kh. & M. Ashraf. 2005. Bone marrow cell transplantation in clinical perspective. J. Mol. Cell. Cardiol. 38: 225-235. (Pubitemid 40215191) (Pubitemid 40215191)
10. Menasché, R 2008. Skeletal myoblasts and cardiac repair. J. Mol. Cell. Cardiol. 45: 545-553.
11. Winter, E. M., R. W. Grauss, B. Hogers, et al. 2007. Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardiumderived cells into the infarcted mouse heart. Circulation 116: 917-927.
12. Thomson, J. A., J. Itskovitz-Eldor, S. S. Shapiro, et al. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
13. Lavon, N., K. Narwani, T. Golan-Lev, et al. 2008. Derivation of euploid human embryonic stem cells from aneuploid embryos. Stem Cells 26: 1874-1882.
14. Kehat, I., D. Kenyagin-Karsenti, M. Snir, et al. 2001. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108: 407-414.
15. Mummery, C., D. Ward, C. E. Van Den Brink, et al. 2002. Cardiomyocyte differentiation of mouse and human embryonic stem cells. J. Anat. 200: 233-242. (Pubitemid 34467315) (Pubitemid 34467315)
16. Fukuda, K. & S. Yuasa. 2006. Stem cells as a source of regenerative cardiomyocytes. Circ. Res. 98: 1002-1013. (Pubitemid 43755221) (Pubitemid 43755221)
17. Li, S. C., L. Wang, H. Jiang, et al. 2008. Stem cell engineering for treatment of heart diseases: potentials and challenges. Cell. Biol. Int. 33: 255-267.
18. Xu, C., S. Police, N. Rao, et al. 2002. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ. Res. 91: 501-508.
19. Mummery, C., D. Ward-van Oosterwaard, P. Doevendans, et al. 2003. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107: 2733-2740.
20. Satin, J., I. Kehat, O. Caspi, et al. 2004. Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J. Physiol. 559: 479-496.
21. Satin, J., I. Itzhaki, S. Rapoport, et al. 2008. Calcium handling in human embryonic stem cell-derived cardiomyocytes. Sfem Cells 26: 1961-1972.
22. He, J. Q., Y. Ma, Y. Lee, et al. 2003. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ. Res. 93: 32-39.
23. 2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells 24: 236-245.
24. Liu, J., J. D. Fu, C. W. Siu, et al. 2007. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cells 25: 3038-3044.
25. 2+ stores and angiotensin-II/endothelin-1 signaling pathway are functional in human embryonic stem cell-derived cardiomyocytes. Stem Cells 26: 3130-3138.
26. Less, H., M. Shilkrut, I. Rubinstein, et al. 1999. Cardiac dysfunction in murine autoimmune myocarditis. J. Autoimmun. 12: 209-220. (Pubitemid 29223052) (Pubitemid 29223052)
27. Proven, A., H. L. Roderick, S. J. Conway, et al. 2006. Inositol 1, 4, 5-trisphosphate supports the arrhythmogenic action of endothelin-1 on ventricular cardiac myocytes. J. Cell. Sci. 119: 3363-3375.
28. Salas, M. A., M. G. Vila-Petroff, J. Palomeque, et al. 2001. Positive inotropic and negative lusitropic effect of angiotensin II: intracellular mechanisms and second messengers. J. Mol. Cell. Cardiol. 33: 1957-1971.
29. 3)receptor type 2-deficient mice. Circ. Res. 96: 1274-1281.
30. 2+ signalling in cat atrial excitation-contraction coupling and arrhythmias. J. Physiol. 555: 607-615.
31. Barac, D. Y., N. Zeevi-Levin, G. Yaniv, et al. 2005. The 1, 4, 5-inositol trisphosphate pathway is a key component in Fas-mediated hypertrophy in neonatal rat ventricular myocytes. Cardiovasc. Res. 68: 75-86.
32. Yeh, Y. H., J. R. Ehrlich, X. Qi, et al. 2007. Adrenergic control of a constitutively active acetylcholine-regulated potassium current in canine atrial cardiomyocytes. Cardiovasc. Res. 74: 406-415.
33. Burns, K. & M. Michalak. 1993. Interactions of calreticulin with proteins of the endoplasmic and sarcoplasmic reticulum membranes. FEBS Lett. 318: 181-185. (Pubitemid 23065949) (Pubitemid 23065949)
34. 2+)storing proteins in endo/sarcoplasmic reticulum during differentiation of rat cardiomyocytes. J. Mol. Cell. Cardiol. 28: 553-562.
35. Michalak, M., J. Lynch & J. Groenendyk. 2002. Calreticulin in cardiac development and pathology. Biochim. Biophys. Acta 1600: 32-37.
36. Méry, A., F. Aimond, C. Ménard, et al. 2005. Initiation of embryonic cardiac pacemaker activity by inositol 1, 4, 5-trisphosphate-dependent calcium signaling. Mol. Biol. Cell. 16: 2414-2423. (Pubitemid 40632222) (Pubitemid 40632222)
37. Lynch, J. M., K. Chilibeck, Y. Qui, et al. 2006. Assembling pieces of the cardiac puzzle; calreticulin and calciumdependent pathways in cardiac development, health, and disease. Trends. Cardiovasc. Med. 16: 65-69.
38. Lozyk, M. D., S. Papp, X. Zhang, et al. 2006. Ultrastructural analysis of development of myocardium in calreticulin-deficient mice. BMC Dev. Biol. 6: 54.
39. Lipp, P., M. Laine, S. C. Tovey, et al. 2000. Functional InsP3 receptors that may modulate excitationcontraction coupling in the heart. Curr. Biol. 10: 939-942. (Pubitemid 30647625) (Pubitemid 30647625)
40. 3 receptors and inositol phosphates in the heart: evolutionary artefacts or active signal transducers? Pharmacol. Ther. 107: 240-251.
41. 2+ signaling in cardiac myocyte excitation-transcription coupling. J. Clin. Invest. 116: 675-682.
42. Kockskämper, J., A. V. Zima & H. L. Roderick. 2008. Emerging roles of inositol 1, 4, 5-trisphosphate signaling in cardiac myocytes. J. Mol. Cell. Cardiol. 45: 128-147.
43. Rosemblit, N., M. C. Moschella, E. Ondriasá, et al. 1999. Intracellular calcium release channel expression during embryogenesis. Dev. Biol. 206: 163-177. (Pubitemid 29100473) (Pubitemid 29100473)
44. Kapur, N. & K. Banach. 2007. Inositol-1, 4, 5trisphosphate-mediated spontaneous activity in mouse embryonic stem cell-mediated cardiomyocytes. J. Physiol. 581: 1113-1127.
45. 3 signaling in cardiac myocytes. J. Physiol. 581: 883-884.